This Study Has Been Designed to Support the Working Hypothesis That Emergency Surgery in a Colon Obstruction Neoplasm is Better Than Stent Bridge Due to Better Oncological Outcomes, Analyzing the Importance of ERAS Programs in Emergency Colon Obstruction Surgery.
EUCOBS
European Study in Colon Obstruction
1 other identifier
observational
100
1 country
1
Brief Summary
This study has been designed to support the working hypothesis that emergency surgery in a colon obstruction neoplasm is better than stent bridge due to better oncological outcomes. The primary objective is to analyse the importance of ERAS program implementation in emergency colon obstruction surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 24, 2025
CompletedFirst Posted
Study publicly available on registry
October 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
ExpectedOctober 2, 2025
September 1, 2025
10 months
September 24, 2025
September 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative complications
The primary objective is to analyse the importance of ERAS program implementation in emergency colon obstruction surgery
From enrollment to 90 days
Secondary Outcomes (5)
1 year survival analysis
360 days after surgery
Overall survival
365 days after surgery
disease-related survival
365 days after surgery
disease-free survival
365 days after surgery
Relationship between stent bridge and colon perforation
60 days after stent placement
Study Arms (2)
Urgent
Patients with urgent surgery
Elective
Patients with elective surgery
Eligibility Criteria
Adult patients (aged \>18 years) with a diagnosis of Malignant obstruction colorectal cancer.
You may qualify if:
- All adult patients (aged \>18 years) with a diagnosis of Malignant obstruction colorectal cancer. Informed consent will be obtained from all subjects who will participate in the study voluntarily.
- ASA I, II and III
- No more than 5 days from symptoms onset.
- Absence of proximal colon severe dilatation( no more than 8 centimeters), severe malnutrition.
- No Inmunocompromised patients
- Patients suffer from segmentary colectomy, with or without anastomosis with o witjhout lateral ileostomy
- Patients suffer from Hartmann procedure.
You may not qualify if:
- Patient refusal.
- Patients under 18 years of age.
- ASA IV
- Stent placement
- ICU stay more than 2 days
- Peritonitis
- Out of protocol if patient would need total parenteral nutrition(NPT) during postoperative or Clavien-Dindo more or equal than II.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Urduliz
Bilbao, Vizcaya, 49600, Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
September 24, 2025
First Posted
October 2, 2025
Study Start
July 1, 2025
Primary Completion
April 30, 2026
Study Completion (Estimated)
April 30, 2027
Last Updated
October 2, 2025
Record last verified: 2025-09